Pharma Focus Asia

Repligen

LATEST NEWSRead more...

24

Jul 2024

BeiGene Launches U.S. Biologics Manufacturing and R&D Facility, Advancing Global Expansion to Serve More Patients

BeiGene Ltd a global oncology company has launched its flagship US facility at the Princeton West Innovation Campus in Hopewell NJ This advanced site features cuttingedge biologics

24

Jul 2024

Brenig Therapeutics Raises $65 Million in Series A Funding to Advance Pre-Clinical Pipeline for Parkinson’s Disease

Brenig Therapeutics Inc a trailblazer in neurologyfocused drug development utilizing an AIMLbased discovery platform has successfully completed a million Series A funding round The round was led by New

24

Jul 2024

Flagship Pioneering Introduces Abiologics: Revolutionizing Biotherapeutics with Advanced Capabilities

Flagship Pioneering has introduced Abiologics a new bioplatform company that aims to transform the field of biologics through the development of a novel class of medicines called Synteins

23

Jul 2024

MasterControl Introduces GxPAssist AI to Enhance Life Science Processes

MasterControl a leader in manufacturing and quality management software for regulated industries has introduced GxPAssist AI a suite of generative artificial intelligence AI tools designed to optimize processes for quality and manufacturing professionals These tools aim to enhance efficiency and ens...

23

Jul 2024

FDA Grants Approval for Samsung Bioepis’ EPYSQLI® as a Biosimilar to Soliris®

Samsung Bioepis Co Ltd has received FDA approval for EPYSQLI eculizumabaagh as a biosimilar to Soliris eculizumab EPYSQLI is indicated for treating paroxysmal nocturnal hemoglobinuria PNH to reduce hemolysis and atypical hemolytic uremic syndrome to inhibit complementmediated

22

Jul 2024

Everest Medicines Begins Dosing in China for Global Phase 2b Trial of Zetomipzomib for Lupus Nephritis

Everest Medicines has announced the dosing of the first Chinese patient with zetomipzomib in the global Phase b PALIZADE trial targeting active lupus nephritis Zetomipzomib

Solovpe

press releasesRead more...

24

Jul 2024

Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics

Triastek Inc a global leader in D printing pharmaceuticals today announced that it has entered into a research collaboration and platform technology license agreement with BioNTech SE a next generation

24

Jul 2024

Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs

Waters Corporation announced today the global release of the TA Instruments Rapid ScreeningDifferential Scanning Calorimeter designed for biopharmaceutical developers

24

Jul 2024

IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Multiple Sclerosis

IASO Biotechnology a biopharmaceutical company dedicated to discovering developing manufacturing and commercializing innovative cell therapy and antibody products announced that the investigational new drug application for the independently developed

23

Jul 2024

QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs

QDX a computational drug discovery company today announced a collaboration with Prelude Therapeutics a clinicalstage precision oncology company targeting undisclosed previously undrugged

23

Jul 2024

GC Cell and Lukas Announce Strategic Cooperation Agreement to Jointly Tap into the Innovative Cell Therapy including and beyond Korean and Taiwanese Market

GC Cell Corporation and Lukas Biomedical Co Ltd has formally signed an international strategic cooperation agreement GC Cell is a fully integrated pioneer in cell and gene therapy

22

Jul 2024

Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia

Biophytis SA a clinicalstage biotechnology company specializing in the development of treatments for agerelated diseases today announces the deployment of its partnership

30 - 01

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

30 - 01

Jul 2024

Inalab 2023

Jakarta Barat, Indonesia

13 - 14

Aug 2024

ADVANCING BUSINESS, TECHNOLOGY AND INNOVATION

Songdo Convensia, Incheon, South Korea

13 - 14

Aug 2024

12 YEARS OF EXCELLENCE: SOUTH KOREA’S BIOLOGICS

Songdo Convensia, Incheon, South Korea

19 - 21

Aug 2024
Hexagon - Expert Insights Webinar
MFA + MMA 2024
4th Annual Cleaning Validation 2024
2nd Annual Pharma Impurity Conclave 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

  • 5

    The Emergence of Organ-on-chips for Diseases Studies and Drug Development

    Giuseppe Maruccio

    Full Professor, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce

    Anna Grazia Monteduro

    Researcher, Omnics Research Group @ University of Salento, CNR-Nanotec, and INFN-Lecce

    Silvia Rizzato

    Researcher, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce

    Giusi Caragnano

    PhD Student, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce

KNOWLEDGE BANK

  • Interviews

    Thomson Reuters

    Senior Vice President

    We believe publications such as Pharmafocus Asia are essential in providing professionals with insights into the dynamic and evolving trends of the Pharma industry
  • Articles

    Role of Nutraceutical in Various Diseases - A Review

    DeFelice introduced the term nutraceutical in combining the words nutrition and pharmacy and originally defined it as a food or part of a food that provides medical or health benefits including the prevention and treatment of disease A nutraceutical may be a nutrientdense food like spirulina garlic or soy or a specific dietary component

  • Research Insights

    Beyond Inclusion: Enacting Team Equity in Precision Medicine Research

    To identify meanings of and challenges to enacting equitable diversification of genomics research and specifically precision medicine research PMR teams There have been resounding calls for increased workforce diversity WFD and greater inclusion of underrepresented researchers in genomics and academic science more broadly Growing awareness of systemic racism

  • Case Studies

    Novel Vaccines - Heat Stable Anthrax Vaccine

    Challenge Existing approved Anthrax vaccines are based on cellfree filtrates of disintegrated cells of Bacillus anthracis adsorbed onto an aluminiumhydrogel adjuvant A number of side effects are attributed to these vaccines including poor safety profile and a low immunogenicity necessitating repea

  • White Papers

    NextGen Pharma Takes ‘Smart’ Strides with Internet of Things

    AbstractDigitization of processes and data across the value chain along with the emergence of Internet of Things IoT has transformed the Pharma industry Although IoT is still in the nascent stage of adoption in the Life Sciences industry the use of smart devices and machinetomachine MM communication leveraging SMAC technologies comes at a time when

EDITORIAL SECTION